Armenia Medical Device Compliance Roadmap 2026–2028: Key Deadlines and Action Plan

1. Key takeaways

For 2026–2028, the compliance main line of the Armenian market can be compressed into three differentiated levers: Lever A — the transition period extended to 2027-12-31 together with the import (compliance) certificate system; Lever B — the new QMS rules under Decision No. 43 of 2026 (in force 2026-06-18); Lever C — the consecutive amendments of the classification rules (No. 65 of 2023 and No. 18 of 2025). The GRZAN conclusion: use 2026 for entity and documentation changes, 2027 for the registration sprint and the transition period close-out, and 2028 for routine maintenance. This three-step path can minimize compliance risk without additional investment, provided each step is completed inside its own window.

2. Legal basis

3. Expert insights

Insight 1: The three levers work through different mechanisms but all point to time and cost. Lever A provides time (unregistered devices may be imported until 2027-12-31); Lever B changes the responsibility structure and scheduling certainty (equal standing of the authorized representative, hard ceiling of 90 working days); Lever C affects documentation and inspection cost (classification determines the depth of the documentation list and whether an inspection is mandatory). GRZAN note: the levers can be combined — use the time bought through A, re-optimize classification cost through C, and complete the entity changes through B.

Insight 2: Three hard dates for 2026–2028 must be entered into the company compliance calendar, as tabulated by GRZAN.

Insight 3: Compliance is not a one-time investment but three parallel pipelines. GRZAN note: the three pipelines of an Armenia project are the registration pipeline (classification, catalog, file, testing, inspection, coordination, registration certificate), the import pipeline (import entity, single window, Annex 2 documents, import certificate, customs clearance), and the post-market pipeline (surveillance, periodic reports, corrective actions, changes, response to suspension and cancellation). The three pipelines share the same product master data; inconsistent master data are the main source of rework.

Insight 4: Terminology and version management are a hidden cost. The Union instruments covered by this topic exceed 20 items, with multiple amendments and partial repeals (No. 116 and No. 123 were repealed; No. 28 and No. 38 were amended in 2022; No. 46 was revised in 2021; No. 106 was amended in 2021 and again in 2026; No. 173 was amended in 2023 and again in 2025). GRZAN note: a regulatory tree ledger with a quarterly review mechanism is a necessary investment to control this hidden cost.

4. Practical recommendations

Stage one, 2026 (entity changes and documentation readiness):

1. Rewrite the authorization letter in line with Decision No. 43 of 2026 (three authorities of inspection application, coordination and contract signing, plus joint liability clauses).
2. Re-verify the classification of existing products under Decisions No. 65 of 2023 and No. 18 of 2025 (software and IVDs first).
3. Establish the dual-entity architecture of importer plus authorized representative, with separate authorization documents.
4. Set up the regulatory tree ledger and the quarterly review mechanism, and retire internal standards citing Decisions No. 116 and No. 123.
5. Submit all change applications for legacy devices registered under national rules before 2026-12-31.

Stage two, 2027 (registration sprint and transition period close-out):

1. Start Union registration: complete the full chain of classification, catalog, file, testing and inspection, and lock in the reference state and at least one acknowledging state.
2. During the transition period, maintain shipment-by-shipment application of import (compliance) certificates under Decision No. 429-Ն to secure supply.
3. Establish the four-step post-market surveillance closed loop of Decision No. 174 (collection, recording, analysis, decision).
4. Enter the combination of report validity of 3 years, application lead time of 90 working days and inspection ceiling of 90 working days into the annual quality plan under Decision No. 106 as amended in 2026.
5. Complete the switch from unregistered to registered status before 2027-12-31 to avoid supply interruption.

Stage three, 2028 (routine maintenance):

1. Submit periodic safety and clinical effectiveness reports for Class 3 devices and implantable Class 2b/3 devices under Decision No. 174.
2. Submit surveillance data according to the unified information database standard of Board Order No. 177 of 2018-11-12.
3. Reserve response resources for the approval of expert opinions for registered devices introduced by the 2021 revision.
4. Undergo scheduled (planned) manufacturing inspections every 3 years, submitting applications with a lead time of 90 working days.
5. Continue tracking follow-up policy on the transition period and updates of the exemption list, and review the regulatory tree quarterly.

5. Verification checklist

1. □ The three hard dates (2026-06-18, 2026-12-31, 2027-12-31) are entered into the company compliance calendar.
2. □ Authorization letter rewritten in line with Decision No. 43 of 2026.
3. □ Classification re-verification of existing products completed (software and IVDs first).
4. □ Dual-entity architecture of importer and authorized representative established.
5. □ Regulatory tree ledger and quarterly review mechanism established, obsolete references retired.
6. □ Three parallel pipelines (registration / import / post-market) and unified product master data established.
7. □ Four-step surveillance closed loop established under Decision No. 174, with the periodic reporting scope identified (Class 3 plus implantable Class 2b/3).
8. □ The 3-year inspection cycle and the 90 working day lead time entered into the annual quality plan.

Regulatory information verified as of October 30, 2026.

About GRZAN: GRZAN supports medical device manufacturers entering Armenia and the Eurasian Economic Union with regulatory registration, quality management systems, post-market surveillance and import clearance compliance. For inquiries, contact info@grzanglobal.com.